Why is Alkem Lab falling/rising?

As of 18-Sep, Alkem Laboratories Ltd's stock price is currently at 5,480.00, reflecting an increase of 18.0 (0.33%). The stock has traded in a narrow range today, and while it is performing above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, it has underperformed its sector by 0.72%. Over the past week, the stock has gained 1.62%, and over the past month, it has increased by 2.20%. However, year-to-date, the stock is down 2.67%, and it has seen a significant decline of 10.34% over the past year. The company's management efficiency is highlighted by a high return on equity (ROE) of 17.69% and a low debt-to-equity ratio, which may contribute positively to investor sentiment. Despite this, the stock faces challenges such as poor long-term growth prospects, as indicated by modest net sales and operating profit growth rates, and a decrease in promoter confidence, with a 2.09% reduction in their stake.
Broader market context shows that while Alkem Laboratories has experienced a short-term gain, it has underperformed compared to the Sensex, which has risen by 1.80% over the past week. The broader market has also outperformed Alkem on a year-to-date basis, with the Sensex up 6.24%. This context suggests that while Alkem's stock may be experiencing some upward movement, it is not keeping pace with the overall market trends, which could be a concern for investors. The declining delivery volume indicates reduced investor participation, which may further pressure the stock's performance in the near term.